Research Priorities in Integrated Functional Medicine: Where Evidence Is Needed

Throughout this library, articles have labelled evidence honestly: some interventions are well supported, many are emerging, some rest on tradition, and some have limited or uncertain support. That honesty reveals a research agenda. Integrated Functional Medicine rests on sound principles, but many of its specific practices, and the model as a whole, need better evidence. This article sets out where evidence is most needed, which research methods suit these questions, and how practitioners can contribute.

Where evidence is needed

1. Validation of tests

Many tests used in functional practice lack evidence of analytical validity, clinical validity or clinical utility: comprehensive stool profiles, food specific IgG panels, organic acid panels, salivary hormone profiles, intracellular nutrient tests and others. Research should establish whether these tests measure what they claim, whether results predict outcomes, and whether using them improves patient care compared with standard assessment.

2. Optimal ranges

Narrower optimal ranges for biomarkers are widely used but rarely validated. Research linking biomarker levels to outcomes in diverse populations, and testing whether treating people towards optimal ranges improves outcomes, would clarify which of these ranges are useful and which risk overtreatment.

3. Whole system and multicomponent care

Integrated Functional Medicine is a complex intervention: individualised assessment, multiple coordinated changes and long term follow up. Traditional trials that test one component at a time are poorly suited to it. Frameworks for evaluating complex interventions recommend developing and testing such interventions as whole systems, considering context, implementation and mechanisms.

4. Comparative effectiveness of integrated care models

An observational study at a large academic centre found that patients attending a functional medicine clinic reported greater improvements in health related quality of life than matched patients in primary care, but such studies cannot exclude selection effects. Randomised and pragmatic comparisons of integrated models against usual care, for defined conditions, are needed.

5. Cost effectiveness

Longer consultations, health coaching and multidisciplinary coordination have costs. Evidence on whether they reduce other healthcare use, medicines or disability would inform health systems and payers.

6. Safety and quality of traditional medicines and supplements

Priorities include pharmacovigilance for herbal and traditional medicines, herb drug interaction studies, product quality and contamination research, and better reporting systems for adverse events.

7. Diverse populations

Much research has been conducted in populations of European ancestry and in high income countries. Evidence is needed for people of South Asian, African, East Asian, Latin American and Indigenous ancestries, for low and middle income settings and for socioeconomically disadvantaged groups.

8. Health coaching and behaviour change

Evidence supports health coaching for some outcomes, but questions remain about which models, doses, practitioners and populations benefit most, and how coaching works best within integrated care.

9. Emerging science

The microbiome, nutrigenomics, metabolomics and precision nutrition are advancing rapidly. Research should translate these fields into clinical tools only where validated, avoiding premature commercialisation.

10. Education and workforce

How should practitioners from different professions be trained in integrated methods? Does training change practice and patient outcomes? Research on education is part of the agenda.

Methods suited to these questions

Methodological challenges

• Individualisation: when each patient receives a different plan, trials must test the process or approach rather than a fixed intervention.
• Blinding: difficult for lifestyle and multicomponent interventions, increasing the importance of objective outcomes.
• Placebo and context effects: longer, more attentive consultations produce benefits of their own, which are real but must be distinguished from specific effects in research.
• Outcome selection: outcomes should matter to patients, including function and quality of life, alongside clinical markers.
• Conflicts of interest: commercial interests in tests and supplements require transparency and independent research.

How practitioners can contribute

1. Measure outcomes consistently, using validated patient reported and clinical measures at baseline and follow up.
2. Record data systematically, in forms that allow aggregation and audit.
3. Report adverse events from supplements and traditional medicines to the appropriate authorities.
4. Publish honestly, including case series and negative findings, with appropriate consent and ethics.
5. Collaborate with researchers and academic institutions.
6. Join practice research networks and registries where available.
7. Appraise critically and avoid adopting new tests and treatments before evidence supports them.

IIFM’s commitment

IIFM’s editorial policy of labelling evidence, its emphasis on outcome measurement and its commitment to review articles as evidence changes are intended to support a practice that uses evidence honestly and helps generate it. As research answers open questions, the library’s labels will change: some emerging practices will become established, and others will be set aside.

Evidence as an ongoing project

A field that is honest about its evidence can be trusted, and a field that generates evidence can improve. The gaps described here are not weaknesses to conceal but questions to answer. Practitioners, researchers and educators each have a part to play in answering them.